Bayer AG operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bayer AG with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £30.82 billion [US$38.53 billion]
of which 56%
(35.68 billion Euro [US$39.51 billion]
of which 69%
was Pharmaceuticals), and
based in Switzerland
(51.94 billion Swiss Francs [US$52.30 billion]
of which 66%
was Innovative Medicines).
Bayer AG reported sales of 39.59 billion Euro (US$43.84 billion)
December of 2018.
increase of 13.1%
versus 2017, when the company's sales were 35.02 billion Euro.
Despite this increase, sales are still
below the level achieved in 2016, when Bayer AG
reported sales of 46.77 billion Euro.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Bayer AG had sales
of 40.16 billion Euro.
Sales of Cropscience saw an increase
that was more than double the company's growth rate: sales were up
49.0% in 2018, from
9.58 billion Euro to 14.27 billion Euro.
Bayer AG also saw significant increases in sales in
All Other Segments (up 40.5% to 1.61 billion Euro)
Not all segments of Bayer AG experienced an increase in sales in 2018:
sales of Consumer Care fell 7.0% to 5.45 billion Euro.
Bayer AG also experienced decreases in sales in
Pharmaceuticals and Biological Products (down 0.6% to 16.75 billion Euro)
Animal Health (down 4.5% to 1.50 billion Euro)